关键字: 类型:
下载页码(大于0,小于196):
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20 
 单克隆抗体应对最终药物的生产,配制,递送和稳定性方面的挑战 407条(本栏目收费,不能显示细节,电话13136136841)
formulations,93 93 
approaches for formulation development,103 103 
blind men investigating elephant appearance,104 104 
complexity of stability determinations during,105,106 105 106 
dosage form assessment—solid versus liquid dosage forms,93,103 93 103 
liquid formulation development,106,107 106 107 
in silico methods to assessing protein degradation routes,105 105 
stability-indicating assays development,103,105 103 105 
lyophilization,145 145 
as protein therapeutics,3 3 
Mutual diffusion coefficient,169 169 
Needle technology,153,154 153 154 
Newtonian fluid,163,164 163 164 
falling ball viscometer use,166 166 
kinematic viscosity for,165 165 
viscosities,167 167 
“Non-Newtonian” fluid,163,164 163 164 
Non-site-specific oxidation,53,54 53 54 
Nonenzymatic peptide fragmentation,62,64 62 64 
antibodies (mAbs)at C-terminus,65 65 
electrospray fragments of mAb,66 66 
freeze-dried mAb,63 63 
hinge region in IgG1 mAbs,64,65 64 65 
pathways for cleavage of peptide bonds,64 64 
Nonreducible cross-linking in mAbs,66,67 66 67 
Oxidation,51 51 
of Cys,59,62 59 62 
histidine oxidation,53,54 53 54 
met oxidation,52,53 52 53 
Trp oxidation,54,56 54 56 
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3